Venter discusses the future of genomics

03/12/2013 | Medscape (free registration)

The next step in the genomics revolution is to incorporate genomics into drug testing and development, says genomics pioneer J. Craig Venter. As genome sequencing has gotten faster and cheaper, it has also gotten less accurate, and a diploid genome map is necessary to pinpoint the genetics associated with a given disease, Venter said. His new institute on the University of California, San Diego, campus will focus on synthetic and environmental genomics research as well as the relationship between microbiomes and disease.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI